Involvement of Bacteria Other Than Clostridium difficile in Antibiotic-Associated Diarrhoea

Sarah Larcombe1, Melanie L Hutton1, Dena Lyras1

  • 1Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia 3800.

Trends in Microbiology
|February 22, 2016
PubMed

Insights

Antibiotic-associated diarrhoea (AAD) is a common side effect of antibiotics. This review explores bacterial causes beyond Clostridium difficile, focusing on other pathogens and their virulence factors in AAD development.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Antibiotic-associated diarrhoea (AAD) is a frequent adverse effect of antimicrobial therapy.
  • While Clostridium difficile causes approximately 25% of AAD cases, the etiology of most remains unknown.
  • Other bacteria like Clostridium perfringens, Staphylococcus aureus, and Klebsiella oxytoca are implicated in AAD.

Purpose of the Study:

  • To re-examine antibiotic-associated diarrhoea (AAD).
  • To present current perspectives on AAD, focusing on non-C. difficile bacterial causes.
  • To explore the virulence factors involved in the pathogenesis of AAD.

Main Methods:

  • This study is a review of existing literature on antibiotic-associated diarrhoea.
  • The review focuses on bacterial pathogens other than Clostridium difficile.
  • Virulence factors contributing to AAD pathogenesis are examined.

Main Results:

  • Clostridium difficile is a common cause of AAD, but not the sole infectious agent.
  • Numerous other bacterial species contribute to AAD pathogenesis.
  • Host factors, specific microbial agents, and antibiotic regimens influence AAD development.

Conclusions:

  • Understanding non-C. difficile bacterial causes of AAD is crucial for effective management.
  • Further research into the virulence factors of these alternative pathogens is warranted.
  • AAD is a multifactorial condition requiring consideration of host, pathogen, and treatment variables.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
538
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
14
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
12
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
855
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.9K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
747